{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:53:44Z","timestamp":1790902424100,"version":"4.1.0"},"reference-count":45,"publisher":"British Editorial Society of Bone & Joint Surgery","issue":"10","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/boneandjoint.org.uk\/TDM"}],"content-domain":{"domain":["boneandjoint.org.uk"],"crossmark-restriction":true},"short-container-title":["Bone Jt Open"],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Fracture-related infection (FRI) is a major cause of morbidity following limb fracture surgery. Topical vancomycin has gained popularity as an adjunct to systemic prophylaxis; however, concerns regarding nephrotoxicity, impaired bone healing, and wound complications remain. This review aims to evaluate the efficacy and safety of intraoperative topical vancomycin powder in preventing FRI in patients undergoing surgical management of upper or lower limb fractures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of randomized controlled trials (RCTs) was conducted in February 2026. Comprehensive searches of Medline, EMBASE, and Cochrane CENTRAL were performed. Trials were included if they randomized patients with limb fractures between intraoperative topical vancomycin powder and no vancomycin, placebo, or standard care. The primary outcome was FRI or deep surgical site infection (SSI). Secondary outcomes included time to FRI, organism profile, antimicrobial resistance, superficial SSI, nonunion, revision surgery, wound healing problems, renal impairment, and other reported complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five studies involving 1,373 patients were included. Topical vancomycin significantly reduced FRI rates compared with controls (risk ratio (RR) 0.64 (95% CI 0.43 to 0.96); p = 0.030). A significant reduction in FRIs caused by gram-positive organisms was identified in patients given topical vancomycin (RR 0.41 (95% CI 0.24 to 0.71); p = 0.001). No differences in FRIs caused by gram-negative or resistant organisms were identified. There were no significant differences in superficial SSI, nonunion rates, wound healing, or other complications. Topical vancomycin was not associated with a significant risk of nephrotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Topical vancomycin powder may be a safe and effective adjunct to standard systemic prophylaxis for preventing FRI, particularly in reducing gram-positive infections. However, current evidence is limited by a lack of high-quality RCTs and small sample sizes. A large, definitive RCT is needed to determine the efficacy, safety, and cost-effectiveness of topical vancomycin in limb fracture surgery.<\/jats:p>\n                    <jats:p>\n                      Cite this article:\n                      <jats:italic>Bone Jt Open<\/jats:italic>\n                      \u00a02026;7(10):1253\u20131260.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1302\/2633-1462.710.bjo-2026-0126.r1","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:01:06Z","timestamp":1790899266000},"page":"1253-1260","update-policy":"https:\/\/doi.org\/10.1302\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of topical vancomycin in preventing surgical site infection following fracture surgery"],"prefix":"10.1302","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7255-8238","authenticated-orcid":false,"given":"Neel","family":"Badhe","sequence":"first","affiliation":[{"name":"Department of Orthopaedics and Trauma, Academic Unit of Injury, Recovery and Inflammation Sciences, University of Nottingham, Nottingham, UK"},{"name":"School of Medicine, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Hutton","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-9552","authenticated-orcid":false,"given":"Abbas","family":"See","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Trauma, Academic Unit of Injury, Recovery and Inflammation Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1410-1756","authenticated-orcid":false,"given":"Benjamin J.","family":"Ollivere","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Trauma, Academic Unit of Injury, Recovery and Inflammation Sciences, University of Nottingham, Nottingham, UK"},{"name":"Musculoskeletal, Surgery, Inflammation and Recovery Theme, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-537X","authenticated-orcid":false,"given":"Ben Arthur","family":"Marson","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Trauma, Academic Unit of Injury, Recovery and Inflammation Sciences, University of Nottingham, Nottingham, UK"},{"name":"Musculoskeletal, Surgery, Inflammation and Recovery Theme, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"42","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"11","key":"2026100200010457026_b1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14111095","article-title":"Fracture-related infections: current status and perspectives from the International Society of Antimicrobial Chemotherapy","volume":"14","author":"Lourtet-Hasco\u00ebt","year":"2025","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"2026100200010457026_b2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.injury.2016.09.019","article-title":"Infection after fracture fixation: current surgical and microbiological concepts","volume":"49","author":"Metsemakers","year":"2018","journal-title":"Injury"},{"issue":"1","key":"2026100200010457026_b3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1302\/0301-620X.106B1.BJJ-2023-0279.R2","article-title":"A population-based epidemiological and health economic analysis of fracture-related infection","volume":"106-B","author":"Foster","year":"2024","journal-title":"Bone Joint J"},{"issue":"4","key":"2026100200010457026_b4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jcot.2015.04.004","article-title":"Surgical site infection in orthopedic trauma: a case-control study evaluating risk factors and cost","volume":"6","author":"Thakore","year":"2015","journal-title":"J Clin Orthop Trauma"},{"issue":"6","key":"2026100200010457026_b5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.injury.2017.03.030","article-title":"Infection after fracture fixation of the tibia: analysis of healthcare utilization and related costs","volume":"48","author":"Metsemakers","year":"2017","journal-title":"Injury"},{"issue":"6","key":"2026100200010457026_b6","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S1473-3099(23)00503-0","article-title":"The global burden of fracture-related infection: can we do better?","volume":"24","author":"Metsemakers","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026100200010457026_b7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jor.2023.10.032","article-title":"Surgical site application of antibiotics: a potential game changer for fracture-related infection care and antibiotic stewardship","volume":"46","author":"Bangash","year":"2023","journal-title":"J Orthop"},{"issue":"5","key":"2026100200010457026_b8","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.7259","article-title":"Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial","volume":"156","author":"Major Extremity Trauma Research Consortium (METRC)","year":"2021","journal-title":"JAMA Surg"},{"key":"2026100200010457026_b9","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1097\/BOT.0000000000000801","article-title":"Local antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: a multicenter, randomized, controlled trial (VANCO Study)","volume":"31 Suppl 1","author":"O\u02bcToole","year":"2017","journal-title":"J Orthop Trauma"},{"issue":"11","key":"2026100200010457026_b10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73210","article-title":"Locally delivered antibiotics in fracture-related infection","volume":"16","author":"Mills","year":"2024","journal-title":"Cureus"},{"key":"2026100200010457026_b11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jor.2024.03.040","article-title":"Local vancomycin administration in orthopaedic surgery - a systematic review of comparative studies","volume":"55","author":"Lameire","year":"2024","journal-title":"J Orthop"},{"issue":"4","key":"2026100200010457026_b12","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.OA.25.00157","article-title":"Local antibiotic delivery systems and their applications in orthopaedic surgery","volume":"10","author":"Hoveidaei","year":"2025","journal-title":"JB JS Open Access"},{"issue":"24","key":"2026100200010457026_b13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247461","article-title":"Evidence for local antibiotics in the prevention of infection in orthopaedic trauma","volume":"11","author":"Flores","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"2026100200010457026_b14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ocl.2015.06.010","article-title":"Applications of local antibiotics in orthopedic trauma","volume":"46","author":"Cancienne","year":"2015","journal-title":"Orthop Clin North Am"},{"issue":"22","key":"2026100200010457026_b15","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2106\/JBJS.O.00072","article-title":"Local injection of aminoglycosides for prophylaxis against infection in open fractures","volume":"97-A","author":"Lawing","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"2026100200010457026_b16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/BOT.0000000000001863","article-title":"Vancomycin powder use in fractures at high risk of surgical site infection","volume":"35","author":"Qadir","year":"2021","journal-title":"J Orthop Trauma"},{"issue":"2","key":"2026100200010457026_b17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1460408620978142","article-title":"Evaluating the efficacy of topical vancomycin powder in the treatment of open lower extremity fractures","volume":"24","author":"Vaida","year":"2022","journal-title":"Trauma"},{"issue":"4","key":"2026100200010457026_b18","doi-asserted-by":"publisher","first-page":"113093","DOI":"10.1016\/j.injury.2026.113093","article-title":"Should vancomycin powder be used in all ORIF wounds at closure of the case to prevent infections?","volume":"57","author":"Hebert-Seropian","year":"2026","journal-title":"Injury"},{"issue":"1","key":"2026100200010457026_b19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jor.2018.01.032","article-title":"Topical vancomycin and its effect on survival and migration of osteoblasts, fibroblasts, and myoblasts: an in vitro study","volume":"15","author":"Liu","year":"2018","journal-title":"J Orthop"},{"issue":"2","key":"2026100200010457026_b20","doi-asserted-by":"publisher","DOI":"10.14444\/4012","article-title":"The effects of topical vancomycin on mesenchymal stem cells: more may not be better","volume":"11","author":"Chu","year":"2017","journal-title":"Int J Spine Surg"},{"issue":"1","key":"2026100200010457026_b21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/BOT.0000000000001866","article-title":"Systemic absorption and nephrotoxicity associated with topical vancomycin powder for fracture surgery","volume":"35","author":"O\u2019Toole","year":"2021","journal-title":"J Orthop Trauma"},{"issue":"5 Suppl 1","key":"2026100200010457026_b22","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.ajic.2006.05.220","article-title":"Antimicrobial resistance in gram-positive bacteria","volume":"34","author":"Rice","year":"2006","journal-title":"Am J Infect Control"},{"issue":"5","key":"2026100200010457026_b23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","article-title":"Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"30","author":"Appelbaum","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"2026100200010457026_b24","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"4","author":"Chandler","year":"2019"},{"issue":"7","key":"2026100200010457026_b25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2026100200010457026_b26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026100200010457026_b27","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"Altman","year":"2024"},{"issue":"1","key":"2026100200010457026_b28","doi-asserted-by":"publisher","DOI":"10.26502\/acbr.50170148","article-title":"Use of Southampton Scoring for wound healing in post-surgical patients: our experience in semi-urban setup","volume":"05","author":"Gorad","year":"2021","journal-title":"Arch Clin Biomed Res"},{"issue":"7","key":"2026100200010457026_b29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63694","article-title":"Effect of topical vancomycin on surgical site infections in ankle fractures: a randomized, double-blind, controlled trial","volume":"16","author":"Acosta-Olivo","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"2026100200010457026_b30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cjtee.2023.11.006","article-title":"Does topical vancomycin prevent fracture-related infections in closed fractures undergoing open reduction and internal fixation? A randomised controlled trial","volume":"27","author":"Gandhi","year":"2024","journal-title":"Chin J Traumatol"},{"key":"2026100200010457026_b31","doi-asserted-by":"publisher","DOI":"10.31661\/gmj.v12i.3382","article-title":"Efficacy of intraarticular vancomycin in preventing infection in patients undergoing hip hemiarthroplasty","volume":"13","author":"Mohammadhoseini","year":"2024","journal-title":"Galen Med J"},{"issue":"4","key":"2026100200010457026_b32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/BOT.0000000000002767","article-title":"Does topical vancomycin powder use in fracture surgery change bacteriology and antibiotic susceptibilities? An analysis of the VANCO Trial","volume":"38","author":"Joshi","year":"2024","journal-title":"J Orthop Trauma"},{"issue":"1","key":"2026100200010457026_b33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BOT.0000000000002458","article-title":"Application of Bayesian methods to help interpret the VANCO trial results","volume":"37","author":"O\u2019Hara","year":"2023","journal-title":"J Orthop Trauma"},{"issue":"9","key":"2026100200010457026_b34","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.69605\/ijlbpr_14.9.2025.251","article-title":"A comparative study to evaluate efficacy of vancomycin powder in adults with open fractures with risk of surgical site infection","volume":"14","author":"Rathore","year":"2025","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"issue":"1","key":"2026100200010457026_b35","doi-asserted-by":"publisher","DOI":"10.3892\/br.2021.1490","article-title":"Mechanisms of gram-positive vancomycin resistance (Review)","volume":"16","author":"Selim","year":"2022","journal-title":"Biomed Rep"},{"issue":"9","key":"2026100200010457026_b36","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1021\/acsinfecdis.1c00318","article-title":"Vancomyxins: vancomycin-polymyxin nonapeptide conjugates that retain anti-gram-positive activity with enhanced potency against gram-negative strains","volume":"7","author":"van Groesen","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"1","key":"2026100200010457026_b37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1139\/cjm-2019-0309","article-title":"Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria","volume":"66","author":"M\u00fchlberg","year":"2020","journal-title":"Can J Microbiol"},{"issue":"4","key":"2026100200010457026_b38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7150\/jbji.26301","article-title":"Antibiotic elution characteristics and pharmacokinetics of gentamicin and vancomycin from a mineral antibiotic carrier: an in vivo evaluation of 32 clinical cases","volume":"3","author":"Colding-Rasmussen","year":"2018","journal-title":"J Bone Jt Infect"},{"issue":"4","key":"2026100200010457026_b39","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000091","article-title":"Early application of topical antibiotic powder in open-fracture wounds: a strategy to prevent biofilm formation and infections","volume":"3","author":"Burbank","year":"2020","journal-title":"OTA Int"},{"issue":"4","key":"2026100200010457026_b40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1302\/2633-1462.34.BJO-2022-0009.R1","article-title":"Does cumulative topical antibiotic powder use increase the risk of drug induced acute kidney injury in fracture patients?","volume":"3","author":"O\u2019Hara","year":"2022","journal-title":"Bone Jt Open"},{"issue":"3","key":"2026100200010457026_b41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1302\/2046-3758.133.BJR-2023-0038.R2","article-title":"Halicin remains active against Staphylococcus aureus in biofilms grown on orthopaedically relevant substrates","volume":"13","author":"Higashihira","year":"2024","journal-title":"Bone Joint Res"},{"issue":"9","key":"2026100200010457026_b42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92261","article-title":"Use of topical antibiotics in open fractures: a systematic review and meta-analysis","volume":"17","author":"Caruana","year":"2025","journal-title":"Cureus"},{"issue":"7","key":"2026100200010457026_b43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1302\/2046-3758.77.BJR-2018-0043.R1","article-title":"The effect of local antibiotic prophylaxis when treating open limb fractures: a systematic review and meta-analysis","volume":"7","author":"Morgenstern","year":"2018","journal-title":"Bone Joint Res"},{"issue":"5","key":"2026100200010457026_b44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/antibiotics9050238","article-title":"Toxic effect of vancomycin on viability and functionality of different cells involved in tissue regeneration","volume":"9","author":"Braun","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"2026100200010457026_b45","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/jor.21343","article-title":"Effect of various concentrations of antibiotics on osteogenic cell viability and activity","volume":"29","author":"Rathbone","year":"2011","journal-title":"J Orthop Res"}],"container-title":["Bone &amp; Joint Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/boneandjoint.org.uk\/doi\/10.1302\/2633-1462.710.BJO-2026-0126.R1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/boneandjoint.org.uk\/doi\/10.1302\/2633-1462.710.BJO-2026-0126.R1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/boneandjoint.org.uk\/doi\/pdf\/10.1302\/2633-1462.710.BJO-2026-0126.R1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:01:08Z","timestamp":1790899268000},"score":1,"resource":{"primary":{"URL":"https:\/\/boneandjoint.org.uk\/doi\/10.1302\/2633-1462.710.BJO-2026-0126.R1"}},"subtitle":["a systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,2]]}},"alternative-id":["10.1302\/2633-1462.710.BJO-2026-0126.R1"],"URL":"https:\/\/doi.org\/10.1302\/2633-1462.710.bjo-2026-0126.r1","relation":{},"ISSN":["2633-1462"],"issn-type":[{"value":"2633-1462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2026-10-2","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}